Epigral

Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on 1st December, 2025

28 Nov, 2025 | 02:36pm • Source: BSE

Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on 25.11.2025.

21 Nov, 2025 | 11:12am • Source: BSE

Epigral Limited has informed the Exchange about Participation in Conference on 19th November, 2025 and 20th November, 2025

17 Nov, 2025 | 10:34am • Source: NSE

Epigral Limited has informed the Exchange about Participation in Conference on 19th November, 2025 and 20th November, 2025.

17 Nov, 2025 | 10:27am • Source: BSE

Epigral Limited has informed the Exchange about Participation in Conference on 19th November, 2025 and 20th November, 2025.

17 Nov, 2025 | 10:27am • Source: BSE

Epigral Limited submits copy of Newspaper Publication pertaining to Un-Audited Financial Results - 30.09.2025

12 Nov, 2025 | 10:51am • Source: BSE

Epigral Limited submits Audio Recording of Conference Call discussing Q2 FY2026 Results.

10 Nov, 2025 | 09:22pm • Source: BSE

Epigral Limited has informed the Exchange regarding Appointment of MR. RAKESH AGRAWAL as Chief Financial Officer of the company w.e.f. November 10, 2025

10 Nov, 2025 | 01:51pm • Source: NSE

Epigral Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Press Release on Un-Audited Financial Results Q2 FY26

10 Nov, 2025 | 01:48pm • Source: NSE

UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025.

10 Nov, 2025 | 01:46pm • Source: BSE

UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025.

10 Nov, 2025 | 01:46pm • Source: BSE

Appointment of Mr. Rakesh Agrawal as a Chief Financial Officer and Key Managerial Personnel of the Company w.e.f. 10.11.2025.

10 Nov, 2025 | 01:42pm • Source: BSE

Appointment of Mr. Rakesh Agrawal as a Chief Financial Officer and Key Managerial Personnel of the Company w.e.f. 10.11.2025.

10 Nov, 2025 | 01:42pm • Source: BSE

Investor Presentation on Un-Audited Financial Results - Q2 FY26.

10 Nov, 2025 | 01:37pm • Source: BSE

Press Release on Un-Audited Financial Results Q2-FY26.

10 Nov, 2025 | 01:35pm • Source: BSE

1. Approved Un-Audited (Standalone & Consolidated) Financial Results of the Company for theSecond Quarter and Half Year ended on 30th September, 2025; and took on...

10 Nov, 2025 | 01:22pm • Source: BSE

Epigral Limited has informed the Exchange about Conference Call on Monday, 10th November, 2025 to discuss Q2 FY26 Results.

05 Nov, 2025 | 06:08pm • Source: BSE

Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve...

04 Nov, 2025 | 11:24am • Source: BSE

CERTIFICATE U/R 74(5) OF SEBI (DP) REGULATIONS.

13 Oct, 2025 | 01:49pm • Source: BSE

Notice of closure of Trading Window w.e.f. 01.10.2025.

27 Sep, 2025 | 11:21am • Source: BSE